Access Consortium sets 2026 priorities to accelerate work sharing and improve patient access to innovative medicines

8th April 2026

Summary:
The Access Consortium, comprising regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland, has announced its priorities for 2026, focusing on strengthening international collaboration and improving the efficiency of work sharing across member countries. The initiative aims to accelerate regulatory assessments, reduce duplication, and support faster patient access to innovative medicines. Key areas include expanding joint reviews, enhancing information sharing, and refining processes to make global regulatory pathways more predictable for developers. These efforts are expected to benefit both industry and patients by enabling more timely availability of new therapies.

Link: https://www.gov.uk/government/news/access-consortium-sets-2026-priorities-to-accelerate-work-sharing-and-improve-patient-access-to-innovative-medicines

Back to Recent News